These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 3121711

  • 1. Tocainide for drug-resistant sustained ventricular tachyarrhythmias.
    Adhar GC, Swerdlow CD, Lance BL, Clay D, Bardy GH, Greene HL.
    J Am Coll Cardiol; 1988 Jan; 11(1):124-31. PubMed ID: 3121711
    [Abstract] [Full Text] [Related]

  • 2. Tocainide for refractory symptomatic ventricular arrhythmias.
    Podrid PJ, Lown B.
    Am J Cardiol; 1982 Apr 01; 49(5):1279-86. PubMed ID: 6801955
    [Abstract] [Full Text] [Related]

  • 3. Short- and long-term therapy with tocainide for malignant ventricular tachyarrhythmias.
    Hohnloser SH, Lange HW, Raeder EA, Podrid PJ, Lown B.
    Circulation; 1986 Jan 01; 73(1):143-9. PubMed ID: 3079677
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
    Reiter MJ, Easley AR, Mann DE.
    Am J Cardiol; 1987 Jun 01; 59(15):1319-24. PubMed ID: 3109228
    [Abstract] [Full Text] [Related]

  • 5. Antiarrhythmic actions of tocainide in canine models of previous myocardial infarction.
    Wallace AA, Stupienski RF, Heaney LA, Gehret JR, Lynch JJ.
    Am Heart J; 1991 May 01; 121(5):1413-21. PubMed ID: 1708198
    [Abstract] [Full Text] [Related]

  • 6. Tocainide: a new oral antiarrhythmic.
    Hasegawa GR.
    Drug Intell Clin Pharm; 1985 May 01; 19(7-8):514-7. PubMed ID: 3928308
    [Abstract] [Full Text] [Related]

  • 7. Mexiletine and tocainide: does response to one predict response to the other?
    Hession M, Blum R, Podrid PJ, Lampert S, Stein J, Lown B.
    J Am Coll Cardiol; 1986 Feb 01; 7(2):338-43. PubMed ID: 3080508
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram.
    Steinbeck G, Bach P, Haberl R.
    J Am Coll Cardiol; 1986 Oct 01; 8(4):949-58. PubMed ID: 3760368
    [Abstract] [Full Text] [Related]

  • 9. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT, Nademanee K, Antimisiaris M, Pacifico A, Pruitt C, Godfrey R, Singh BN.
    Circulation; 1993 Sep 01; 88(3):1072-82. PubMed ID: 8353869
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerance of tocainide during long-term treatment of malignant ventricular arrhythmias.
    Mohiuddin SM, Esterbrooks D, Mooss AN, Dahl JM, Hilleman DE.
    Clin Cardiol; 1987 Aug 01; 10(8):457-62. PubMed ID: 3113792
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study.
    Mahapatra RK, Mahapatra D.
    Angiology; 1986 Apr 01; 37(4):285-93. PubMed ID: 2424347
    [Abstract] [Full Text] [Related]

  • 12. Determinants of the outcome of electrophysiologic study in patients with ventricular tachyarrhythmias.
    Schoenfeld MH, McGovern B, Garan H, Kelly E, Grant G, Ruskin JN.
    J Am Coll Cardiol; 1985 Aug 01; 6(2):298-306. PubMed ID: 4019918
    [Abstract] [Full Text] [Related]

  • 13. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS, Fineberg N, Heger JJ, Miles WM, Kammerling JM, Chang MS, Zipes DP, Prystowsky EN.
    Am J Cardiol; 1988 May 01; 61(13):1024-30. PubMed ID: 3364357
    [Abstract] [Full Text] [Related]

  • 14. Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia.
    Patt MV, Grossbard CL, Graboys TB, Lown B.
    Am J Cardiol; 1988 Nov 03; 62(14):18I-21I. PubMed ID: 2461071
    [Abstract] [Full Text] [Related]

  • 15. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
    Roden DM, Lee JT, Woosley RL, Echt DS.
    Circulation; 1989 Nov 03; 80(5):1247-58. PubMed ID: 2805262
    [Abstract] [Full Text] [Related]

  • 16. Tocainide for drug-resistant ventricular arrhythmias: efficacy, side effects, and lidocaine responsiveness for predicting tocainide success.
    Winkle RA, Mason JW, Harrison DC.
    Am Heart J; 1980 Dec 03; 100(6 Pt 2):1031-6. PubMed ID: 6778191
    [Abstract] [Full Text] [Related]

  • 17. Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide.
    Allen-Narker RA, Roberts CJ, Marshall AJ, Jordan SC, Barritt DW, Goodfellow RM.
    Br J Clin Pharmacol; 1984 Nov 03; 18(5):725-32. PubMed ID: 6439233
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of a new oral agent (tocainide) in the acute treatment of refractory ventricular arrhythmias.
    Ryan W, Engler R, LeWinter M, Karliner JS.
    Am J Cardiol; 1979 Feb 03; 43(2):285-91. PubMed ID: 760482
    [Abstract] [Full Text] [Related]

  • 19. Prophylaxis of primary ventricular fibrillation with tocainide in acute myocardial infarction.
    Campbell RW, Hutton I, Elton RA, Goodfellow RM, Taylor E.
    Br Heart J; 1983 Jun 03; 49(6):557-63. PubMed ID: 6405764
    [Abstract] [Full Text] [Related]

  • 20. Lidocaine (Xylocaine) as an anti-arrhythmic agent.
    Med Lett Drugs Ther; 1971 Jan 08; 13(1):1-2. PubMed ID: 4104507
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.